Private equity returns derive fundamentally from revenue and EBITDA expansion during ownership periods. Multiple arbitrage—buying at 8× EBITDA and selling at 10×—generates meaningful gains but cannot alone produce top-quartile returns. Operational improvements driving revenue growth, margin expansion, and EBITDA compounding create the foundation for exceptional outcomes. Waud Capital Partners reports average revenue growth exceeding 400% for realized investments, a multiple implying companies more than quintuple revenue during hold periods.
Achieving this growth rate systematically, across multiple investments and market cycles, requires examining operational mechanisms beyond general statements about value creation. The specific drivers—add-on acquisition velocity, organic growth initiatives, executive partnership models, and time horizons—reveal how middle-market private equity generates returns through company building rather than financial engineering.
Add-On Acquisition as Growth Engine
Waud Capital Partners’ portfolio companies in healthcare complete an average of more than ten acquisitions during ownership periods, while software investments execute five or more bolt-on transactions. This acquisition velocity differentiates middle-market approaches from venture capital (focused on organic growth) and mega-cap buyouts (where acquisition integration becomes unwieldy at large scale).
Consider illustrative mathematics: a platform acquired at $50 million revenue completing ten acquisitions averaging $10 million revenue each adds $100 million through M&A. Combined with modest 5% annual organic growth over a five-year hold, revenue reaches approximately $190 million—a 280% increase. Achieved growth rates exceeding 400% imply either larger average add-on sizes, higher organic growth rates, or both.
The business development team’s role becomes critical at this acquisition pace. Sourcing 10+ targets, conducting initial diligence, negotiating terms, and integrating operations requires systematic processes that management teams cannot sustain alongside running base business operations. Waud Capital Partners’ dedicated business development professionals work with portfolio companies identifying targets and facilitating transactions.
Kyle Lattner’s recent work on the Mopec Group acquisition exemplifies this approach. The investment follows a “dedicated Medical Device & Supply Services campaign” targeting systematic consolidation opportunities. This language signals proactive market mapping identifying fragmented sectors before individual deals emerge, enabling aggressive acquisition programs post-close.
Organic Growth Acceleration
Add-on acquisitions cannot alone explain 400%+ revenue growth. Organic revenue expansion—same-store sales increases in retail terminology—contributes materially. Mechanisms vary by sector but share common themes: geographic expansion of services, new product or service introductions, pricing optimization, and operational improvements driving volume.
Healthcare services platforms achieve organic growth through multiple levers. Physical therapy clinics increase patient visits per location through enhanced marketing, extended hours, and service line additions. Vision care practices grow through retail eyewear merchandising improvements and medical optometry expansion. Behavioral health facilities improve census through payor contracting, referral source development, and clinical program additions.
Software businesses compound revenue through net revenue retention: existing customers expanding usage, adopting additional products, and renewing at higher prices. Sales and marketing investments accelerate new customer acquisition. Product development creates upsell opportunities. The iOFFICE case demonstrated this potential: revenues quintupled in 2.5 years under Waud Capital ownership before the 2021 sale to Thoma Bravo, with professionalized sales and marketing driving much of the growth.
Executive Partner Contribution
Reeve Waud’s emphasis on “exceptional people driving exceptional value” manifests through executive partner involvement in portfolio companies. Brad Staley’s appointment as Mopec Group Executive Chairman illustrates the model: a proven operator with 25+ years of relevant experience providing hands-on guidance rather than passive board oversight.
Executive partners contribute specific capabilities management teams may lack. Supply chain optimization expertise applies to businesses like Mopec with complex manufacturing and distribution operations. Multi-site operations experience proves valuable for healthcare services platforms scaling from regional to national footprints. Software product development guidance helps SaaS companies enhance offerings and improve customer retention.
This model incurs costs—executive partner compensation and time demands—economically viable only at middle-market scale. A $20 million revenue business cannot afford sophisticated board leadership and advisory resources. A $500 million revenue business may have internal capabilities rendering external executive partners redundant. The $75-200 million equity check range targeted by Waud Capital Partners corresponds to companies benefiting materially from this level of involvement.
Time Horizon and Patient Capital
Compounding returns requires time. A 400% revenue increase over three years implies 71% annualized growth—achievable for high-growth software companies but unrealistic for healthcare services businesses. Over five years, the required annualized rate falls to 38%. Over seven years, just 26% annually reaches the 400% cumulative threshold.
Waud Capital Partners’ track record includes multi-year hold periods enabling this compounding. The Ivy Rehab investment continues through a continuation fund structure rather than forced exit, allowing the platform to mature further. Acadia Healthcare required six years from founding to IPO, with Reeve Waud maintaining board chairmanship for two decades subsequently.
Patient capital stands distinct from permanent capital. Private equity funds have finite lives, ultimately requiring liquidity events. Yet flexibility around exit timing—willingness to hold through temporary market dislocations or to extend holds when organic opportunities remain—enables value maximization versus forced sales.
